Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapy.
作者信息
Huang Xiaomeng, Pomicter Anthony D, Ahmann Jonathan, Qiao Yi, Chen Opal S, George Tracy I, Cruz-Rodriguez Nataly, Guru Sameer Ahmad, Marth Gabor T, Deininger Michael W
机构信息
Utah Center for Genetic Discovery, University of Utah, Salt Lake, UT, USA.
Department of Human Genetics, School of Medicine, University of Utah, Salt Lake, UT, USA.
出版信息
Blood Cancer J. 2024 Oct 14;14(1):179. doi: 10.1038/s41408-024-01157-w.
PMID:39402020
Abstract
摘要
相似文献
[1]
Clonal dynamics of aggressive systemic mastocytosis on avapritinib therapy.
Blood Cancer J. 2024-10-14
[2]
Avapritinib for advanced systemic mastocytosis.
Blood. 2022-10-13
[3]
Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors.
Int J Mol Sci. 2021-3-15
[4]
Avapritinib for Systemic Mastocytosis.
Expert Rev Hematol. 2021-8
[5]
Avapritinib in the Treatment of Systemic Mastocytosis: an Update.
Curr Hematol Malig Rep. 2021-10
[6]
Kit Mutations: New Insights and Diagnostic Value.
Immunol Allergy Clin North Am. 2018-8
[7]
[8]
The new tool "" in advanced systemic mastocytosis.
Hematology Am Soc Hematol Educ Program. 2018-11-30
[9]
[10]
SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis.
Clin Lymphoma Myeloma Leuk. 2025-1
引用本文的文献
[1]
Systemic mastocytosis: current status and challenges in 2024.
Blood Adv. 2025-5-13
本文引用的文献
[1]
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM.
J Allergy Clin Immunol Pract. 2024-12
[2]
[3]
[4]
[5]
[6]
[8]
Identification of two distinct pathways of human myelopoiesis.
Sci Immunol. 2019-5-24
[9]
Zotero 插件